🟢 Immunic, Inc. is trading 5.5% up today, extending a multi-day rebound following analyst target updates

Immunic, Inc. is trading at $14.47 (+5.5%), extending a sharp multi-day rebound from levels near $12 seen earlier in June.

• The move follows recent attention surrounding Q1 2026 earnings, where the company reported a loss of $1.08 per share compared to the $0.93 loss expected by analysts.
• Despite the earnings miss, the stock has gained momentum from multiple updated analyst price targets and a generally bullish longer-term outlook.
• No new company-specific press releases or catalysts have been identified today to account for the continued price appreciation.